CLINICAL_TRIALS
trial_result
· 2024-10-01
Clinical Trial Update: Study to Assess the Efficacy and Safety of Lanreotide Autogel® in Chinese Participants With GEP-NETs [Phase 3]
Summary
Phase 3 study in Chinese participants with gastroenteropancreatic neuroendocrine tumors has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ipsen | Conditions: Gastroenteropancreatic Neuroendocrine Tumor | Phase 3 | Status: COMPLETED | Results posted: 2024-10-01